Equities research analysts at StockNews.com started coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a note issued to investors on Sunday. The firm set a “sell” rating on the stock.
SenesTech Stock Performance
Shares of SenesTech stock opened at $2.50 on Friday. The company has a debt-to-equity ratio of 0.05, a current ratio of 4.68 and a quick ratio of 3.49. The firm has a 50-day moving average of $3.86 and a 200-day moving average of $5.93. SenesTech has a 52-week low of $1.90 and a 52-week high of $78.00.
SenesTech (NASDAQ:SNES – Get Free Report) last posted its quarterly earnings data on Thursday, August 8th. The company reported ($3.08) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($3.20) by $0.12. SenesTech had a negative net margin of 464.09% and a negative return on equity of 168.64%. The firm had revenue of $0.46 million during the quarter, compared to the consensus estimate of $0.49 million. During the same quarter in the previous year, the firm posted ($84.03) EPS.
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Articles
- Five stocks we like better than SenesTech
- What Is WallStreetBets and What Stocks Are They Targeting?
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- MarketBeat Week in Review – 9/16 – 9/20
- 3 Healthcare Dividend Stocks to Buy
- Don’t Miss These 3 Retail Stocks for Fall Gains
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.
